| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.65 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.863 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 coding SNVs) | 0.579 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 coding SNVs) | 0.833 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 intronic SNVs) | 0.097 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 intronic SNVs) | 0.653 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 noncoding SNVs) | 0.775 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 noncoding SNVs) | 0.918 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 splice region SNVs) | 0.832 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 splice region SNVs) | 0.891 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.57 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.838 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 coding SNVs) | 0.446 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 coding SNVs) | 0.8 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 noncoding SNVs) | 0.905 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.944 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.959 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs) | 0.932 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs) | 0.896 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.929 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.896 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.941 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.824 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.748 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.866 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, near splice site) | 0.962 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, near splice site) | 0.896 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, not conserved) | 0.762 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, not conserved) | 0.916 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.708 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.882 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.36 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.915 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.132 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.723 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.951 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.87 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.884 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.405 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.828 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.054 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.686 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.13 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.706 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.846 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.79 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB exonic SNVs) | 0.548 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | GPN-MSA (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB exonic SNVs) | 0.675 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.495 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.811 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 coding SNVs) | 0.454 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 coding SNVs) | 0.781 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 intronic SNVs) | 0.084 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 intronic SNVs) | 0.637 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 noncoding SNVs) | 0.709 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 noncoding SNVs) | 0.898 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 splice region SNVs) | 0.784 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 splice region SNVs) | 0.873 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.397 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.76 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 coding SNVs) | 0.325 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 coding SNVs) | 0.752 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 noncoding SNVs) | 0.888 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.886 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.919 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs) | 0.906 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs) | 0.857 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.903 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.857 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.922 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.783 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.374 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.579 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, near splice site) | 0.939 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, near splice site) | 0.846 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, not conserved) | 0.155 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, not conserved) | 0.571 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.224 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.531 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.341 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.876 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.106 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.691 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.934 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.882 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.927 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.164 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.697 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.016 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.605 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.026 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.547 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.806 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.76 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB exonic SNVs) | 0.498 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | PhyloP 100 (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB exonic SNVs) | 0.631 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, All variants) | 0.96 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, All variants) | 0.908 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Intron (Non-splice)) | 0.885 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Intron (Non-splice)) | 0.852 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) | 0.896 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) | 0.868 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) | 0.887 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) | 0.853 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense) | 0.906 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense) | 0.856 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, RNA gene) | 0.938 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, RNA gene) | 0.882 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Splice) | 0.775 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Splice) | 0.727 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Start loss) | 0.769 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Start loss) | 0.675 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop gain) | 0.783 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop gain) | 0.704 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop loss) | 0.888 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop loss) | 0.796 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Synonymous) | 0.882 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Synonymous) | 0.855 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 3' UTR) | 0.908 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 3' UTR) | 0.862 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | GPN-MSA precomputed hg38 scores (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 5' UTR) | 0.728 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | PhyloP 100-way vertebrate (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 5' UTR) | 0.696 |
|---|